Persistent gaps in the implementation of lipid-lowering therapy in patients with established atherosclerotic cardiovascular disease: A French nationwide study
In real life, one-third of French ASCVD patients was not regularly treated with LLT, highlighting the urgent need to develop implementation strategies for lipid management.
Authors
- Bertrand Cariou (ORCID: https://orcid.org/0000-0002-1580-8040)
- Pierre‐Guillaume Piriou
- Alexandre Bastien
- Jean Ferrières (ORCID: https://orcid.org/0000-0001-6144-1297)
- Thomas Goronflot (ORCID: https://orcid.org/0000-0002-1019-9821)
- Jean‐Noël Trochu (ORCID: https://orcid.org/0000-0003-4742-281X)
- Matthieu Wargny
- Christophe Leux
- Nadège Costa (ORCID: https://orcid.org/0000-0002-1185-3960)
- Mathilde Pouriel
- Stéphanie Duret
- Julie Prax
- Valéry-Pierre Riche
- Sophie Béliard
Institutions
- Centre National de la Recherche Scientifique (FR)
- Université Toulouse III - Paul Sabatier (FR)
- Inserm (FR)
- Université Fédérale de Toulouse Midi-Pyrénées (FR)
- Aix-Marseille Université (FR)
- Centre Hospitalier Universitaire de Nantes (FR)
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR)
- Novartis (France) (FR)
- Hôpital de la Conception (FR)
- Hôpital Rangueil (FR)
- Centre d'Investigation Clinique de Nantes (FR)
- Laboratoire Vision Action Cognition (FR)
- Hôpital Purpan (FR)
- Institut du Thorax (FR)
- Nantes Université (FR)
Publication Details
- Journal
- Diabetes & Metabolism
- Published
- 2025-03-16
- DOI
- https://doi.org/10.1016/j.diabet.2025.101638
- Citations
- 3
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 6.02
Funders
- Novartis